State running out of drug to treat mucormycosis
Updated:
Updated:
Many families, hospitals finding it difficult to source them
Share Article
Many families, hospitals finding it difficult to source them
The supply of the anti-fungal drugs Liposomal Amphotericin B or Amphotericin B, which are vital for treating mucormycosis, is drying up in Tamil Nadu with many patients’ families and hospitals finding it difficult to source them.
Mucormycosis, a serious fungal infection now predominantly affecting people post-COVID-19 with uncontrolled diabetes, has been on the rise in several parts of the country. With cases gradually increasing in Tamil Nadu as well, the demand for the drug has shot up.

Related Keywords

China , Chennai , Tamil Nadu , India , Mansukh Mandaviya , Tamil Nadu Medical Services Corporation , Family Welfare Department , Druggist Association , Lifecare Pharma Private Ltd , Chennai The Hindu , Rajiv Gandhi Government General Hospital , Chennai Chemists , Union Minister , சீனா , சென்னை , தமிழ் நாடு , இந்தியா , மன்சுக் மண்டவியா , தமிழ் நாடு மருத்துவ சேவைகள் நிறுவனம் , குடும்பம் நலன்புரி துறை , போதை மருந்து சங்கம் , ராஜீவ் காந்தி அரசு ஜநரல் மருத்துவமனை , தொழிற்சங்கம் அமைச்சர் ,